We have been working for the past year to get our lab and cell lines (the medical procedure we use in our practice’s lab) certified through the International Cellular Medicine Society (ICMS). ICMS has created guidelines for autologous cell use as well as for labs which function as part of a physician’s medical practice. The Cell Line Advisory and Lab committees have informed us that we passed muster and can now say that we are ICMS certified in these areas. For our lab, this meant multiple visits by a third party lab best practices auditing firm. This is an iterative process where the auditor helped us improve all aspects of the lab. Next came getting our cell lines certified. ICMS defines a cell line as a medical process used by the physician to process cells as part of a medical practice. This includes cell source (where they come from), the actual processing (grown in culture, how? how long? what safety mechanisms are in place?, etc…), and finally how they will be used. The final step toward full ICMS certification is completing the remaining steps to have the ICMS registry track all of our outcome and complications data. While we have been making this transition for months, ICMS is completing it’s web based capabilities to gather this data. We expect other clinics will follow in our footsteps to get ICMS certified and believe that this third party checks and balances (we had no part in the analysis or decision of ICMS to certify our clinic) makes for safer medical practice using stem cells.